Finance · Search · Sign in · Sign up

Claudette buys ALNY 69.67: Alnylam Pharma (ALNY) Receives NoA from USPTO Covering '829 App for RNAi-Mediating, Double-Stranded Molecules


Alnylam Pharma (Nasdaq: ALNY) announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for claims in the Tuschl et al. patent application 12/591,829. The ’829 patent application includes newly allowed claims . ... ...


43 people liked this



See more

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home